Effect of the loss of the type III TGF beta receptor during tumor progression on tumor microenvironment: Preclinical development of TGF beta inhibition and TGF beta-related biomarkers to enhance immunotherapy efficacy.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hanks, BA; Holtzhausen, A; Gimpel, P; Jamieson, R; Campbell, OM; Sun, L; Augustine, CK; Tyler, DS; Osada, T; Morse, M; Ling, LE; Lyerly, HK; Blobe, GC

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

International Standard Serial Number (ISSN)

  • 0732-183X